by European Public Health Alliance | Jun 30, 2022 | Opinion
Guest article by Charlotte Roffiaen, European Policy Advisor at France Assos Santé For many years, the increasing prices of innovative medicines have focused the attention of the European public health community. Affordability issues were threatening both patient...
by European Public Health Alliance | Jun 30, 2022 | Opinion
Article by Julia Aube, Policy Trainee for Healthcare Delivery The COVID-19 pandemic has jeopardised the access and availability of medicines in the EU, therefore, making the EU more resilient regarding the supply of pharmaceuticals is a key objective of...
by European Public Health Alliance | Jun 28, 2022 | Opinion
Things go viral, again With the COVID-19 pandemic still alive and kicking, a monkeypox outbreak “goes viral” in high-income countries, and in a matter of days transitions from an “exotic disease that happens to others” into a household name. In a matter of...
by European Public Health Alliance | May 31, 2022 | Opinion
Guest article by Calum MacKichan & Sarah de Maaker – Standing Committee of European Doctors (CPME) The problem of antimicrobial resistance (AMR) is faced by doctors across Europe on a daily basis who are unable to successfully treat patients who have...
by European Public Health Alliance | May 31, 2022 | Opinion
Guest article by David Garrahy – World Animal Protection Human health and well-being are intrinsically linked to animal health and welfare. The interconnectedness of both in a healthy environment is the key concept of the One Health policy approach that the European...
by European Public Health Alliance | May 31, 2022 | Opinion
Guest article by Jens Jäger – Delegate for Health Research at the Helmholtz Office in Brussels. Twitter: @JensJot. Knowledge is power – an old saying with tremendous meaning today. In the fight against antimicrobial resistances (AMR), this becomes particularly evident...
